Literature DB >> 9488044

Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell-cycle arrest in A431 cells.

M Ohtsubo1, S Gamou, N Shimizu.   

Abstract

A431 cells hyperproduce EGF receptors and possess inactive p53 proteins. It has been suggested that a cyclin-dependent kinase (CDK) inhibitor p21/WAF1 plays a crucial role in the EGF-induced cell-cycle arrest of A431 cells. Here, we investigated the role of WAF1 gene transcription in the EGF-induced cell-cycle arrest by transfecting the 18-mer antisense oligonucleotide which corresponds to the 5' region of WAF1 gene (AS/WAF1). When A431 cells were treated with EGF, a cascade of responses were observed, including immediate hyperphosphorylation of EGF receptor on tyrosine residues, accumulation of WAF1 mRNA and p21/WAF1 protein, dephosphorylation of RB protein which is a substrate of CDK-cyclin, and cell-cycle arrest. In the presence of AS/WAF1, EGF induced the tyrosine-phosphorylation of EGF receptor, but WAF1 mRNA was reduced to a half; accumulation of p21/WAF1 protein and its downstream responses were no longer observed; A431 cells grew continuously. Thus, the transfection of antisense efficiently prevented A431 cells from the EGF-induced arrest. These observations suggest that p21/WAF1 protein is a major effector molecule of the EGF-mediated cell-cycle arrest of A431 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488044     DOI: 10.1038/sj.onc.1201588

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  4 in total

1.  Antisense oligonucleotides and short interfering RNAs silencing the cyclin-dependent kinase inhibitor p21 improve proliferation of Duchenne muscular dystrophy patients' primary skeletal myoblasts.

Authors:  Stefanie Endesfelder; Alexander Kliche; Hanns Lochmüller; Arpad von Moers; Astrid Speer
Journal:  J Mol Med (Berl)       Date:  2004-11-05       Impact factor: 4.599

2.  Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.

Authors:  Judy Wang; Paul Chen; Marko Mrkobrada; Meiduo Hu; Katherine A Vallis; Raymond M Reilly
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-15       Impact factor: 9.236

3.  Transfection of normal primary human skeletal myoblasts with p21 and p57 antisense oligonucleotides to improve their proliferation: a first step towards an alternative molecular therapy approach of Duchenne muscular dystrophy.

Authors:  Stefanie Endesfelder; Sabine Bucher; Alexander Kliche; Regina Reszka; Astrid Speer
Journal:  J Mol Med (Berl)       Date:  2003-05-06       Impact factor: 4.599

4.  The paradoxical functions of EGFR during breast cancer progression.

Authors:  Remah Ali; Michael K Wendt
Journal:  Signal Transduct Target Ther       Date:  2017-01-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.